Canada
For Media Inquiries, Please Contact:
Apotex Inc.
150
Signet Drive,
North York,
ON, M9L 1T9
Canada
Email
Press Center
-
May 26, 2020
-
May 25, 2020
-
April 21, 2020
-
April 17, 2020
-
April 13, 2020
-
March 20, 2020
-
February 4, 2020
-
December 5, 2019Canada’s leading generic drug manufacturer, Apotex, announced today that its first shipment of the drug tamoxifen has been released to the Canadian market. Additional releases are scheduled for December 2019 and January 2020.
-
June 1, 2018Health Canada Leads the Way by Approving the First-Ever Pegfilgrastim Biosimilar in any Highly Regulated World Market
-
September 1, 2017
-
February 9, 2017
-
March 31, 2016Apobiologix®, a Division of Apotex Inc., today launched Grastofil®, its first subsequent entry biologic (SEB) approved in Canada.
-
March 24, 2016Apotex Inc. announced today that it has launched the first generic version of Merck's Nasonex® nasal spray (mometasone furoate monohydrate) in the United States.
